The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mesenchymal Stem Cells Market Research Report 2025

Global Mesenchymal Stem Cells Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1705678

No of Pages : 88

Ask Your Query

Synopsis

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

The global Mesenchymal Stem Cells market was valued at US$ 207.1 million in 2023 and is anticipated to reach US$ 282.9 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.

The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.

Report Scope

The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mesenchymal Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

  • Lonza
  • Thermo Fisher
  • Bio-Techne
  • ATCC
  • MilliporeSigma
  • PromoCell GmbH
  • Genlantis
  • Celprogen
  • Cell Applications
  • Cyagen Biosciences
  • Axol Bioscience

Segment by Type

  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others

Segment by Application

  • Research Institute
  • Hospital
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Human MSC
1.2.3 Mouse MSC
1.2.4 Rat MSC
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institute
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cells Market Perspective (2019-2030)
2.2 Mesenchymal Stem Cells Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2019-2024)
2.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2025-2030)
2.3 Mesenchymal Stem Cells Market Dynamics
2.3.1 Mesenchymal Stem Cells Industry Trends
2.3.2 Mesenchymal Stem Cells Market Drivers
2.3.3 Mesenchymal Stem Cells Market Challenges
2.3.4 Mesenchymal Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cells Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2019-2024)
3.2 Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mesenchymal Stem Cells Revenue
3.4 Global Mesenchymal Stem Cells Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cells Revenue in 2023
3.5 Mesenchymal Stem Cells Key Players Head office and Area Served
3.6 Key Players Mesenchymal Stem Cells Product Solution and Service
3.7 Date of Enter into Mesenchymal Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cells Breakdown Data by Type
4.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2019-2024)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2025-2030)
5 Mesenchymal Stem Cells Breakdown Data by Application
5.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2019-2024)
5.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mesenchymal Stem Cells Market Size (2019-2030)
6.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mesenchymal Stem Cells Market Size by Country (2019-2024)
6.4 North America Mesenchymal Stem Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cells Market Size (2019-2030)
7.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mesenchymal Stem Cells Market Size by Country (2019-2024)
7.4 Europe Mesenchymal Stem Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2019-2030)
8.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size (2019-2030)
9.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024)
9.4 Latin America Mesenchymal Stem Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2019-2030)
10.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Mesenchymal Stem Cells Introduction
11.1.4 Lonza Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Mesenchymal Stem Cells Introduction
11.2.4 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.2.5 Thermo Fisher Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Mesenchymal Stem Cells Introduction
11.3.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.3.5 Bio-Techne Recent Development
11.4 ATCC
11.4.1 ATCC Company Detail
11.4.2 ATCC Business Overview
11.4.3 ATCC Mesenchymal Stem Cells Introduction
11.4.4 ATCC Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.4.5 ATCC Recent Development
11.5 MilliporeSigma
11.5.1 MilliporeSigma Company Detail
11.5.2 MilliporeSigma Business Overview
11.5.3 MilliporeSigma Mesenchymal Stem Cells Introduction
11.5.4 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.5.5 MilliporeSigma Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Detail
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Mesenchymal Stem Cells Introduction
11.6.4 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.6.5 PromoCell GmbH Recent Development
11.7 Genlantis
11.7.1 Genlantis Company Detail
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Mesenchymal Stem Cells Introduction
11.7.4 Genlantis Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.7.5 Genlantis Recent Development
11.8 Celprogen
11.8.1 Celprogen Company Detail
11.8.2 Celprogen Business Overview
11.8.3 Celprogen Mesenchymal Stem Cells Introduction
11.8.4 Celprogen Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.8.5 Celprogen Recent Development
11.9 Cell Applications
11.9.1 Cell Applications Company Detail
11.9.2 Cell Applications Business Overview
11.9.3 Cell Applications Mesenchymal Stem Cells Introduction
11.9.4 Cell Applications Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.9.5 Cell Applications Recent Development
11.10 Cyagen Biosciences
11.10.1 Cyagen Biosciences Company Detail
11.10.2 Cyagen Biosciences Business Overview
11.10.3 Cyagen Biosciences Mesenchymal Stem Cells Introduction
11.10.4 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.10.5 Cyagen Biosciences Recent Development
11.11 Axol Bioscience
11.11.1 Axol Bioscience Company Detail
11.11.2 Axol Bioscience Business Overview
11.11.3 Axol Bioscience Mesenchymal Stem Cells Introduction
11.11.4 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2019-2024)
11.11.5 Axol Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock